Neuroscience 2008
Most rodent studies use doses in the range of 10 micrograms per kilogram to 10 milligrams per kilogram, administered subcutaneously or intraperitoneally
Over the years, it has been studied for obesity, metabolic disorders, and fat loss, and it is now used in wellness and performance clinics as a research peptide
That grew naturally out of the Diabetes, the Insulin research, Lotte's work, and in this organic fashion that is so different than the rest of the pharma industry
Image credit: Matt Fowler KC/Shutterstock.com Glucagon-like peptide-1 receptor agonists (GLP-1RAs) can produce significant weight loss in obese individuals
119,166 Interestingly, the prevalence of this variant varies among different populations, with higher frequencies observed in Asian populations